Wednesday, June 10, 2026

pharma Β· No medical condition. Β· Generalized Myasthenia Gravis

Anaxis Pharma

Anaxis Pharma patent portfolio β€” 0 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Melbourne, AU HQ
2017 Founded
7 Employees
TGA registrant Type
Company details
Status
Public
HQ
Melbourne, AU
Founded
2017
Employees
7
Programs
642
Drugs
673
Patents
0
Intelligence Β· Patents

Anaxis Pharma patents

0 pharmaceutical patents indexed for Anaxis Pharma. 0 expire within 24 months.

Anaxis Pharma has 0 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months β€” use filters for patent-cliff planning.

No patents matched

Try a different expiry filter or check back as we index more USPTO records.

Frequently asked questions

How many patents does Anaxis Pharma have?

0 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Anaxis Pharma patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.